HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$0.52
Day range
$0.52 - $0.56
Year range
$0.30 - $4.28
Market cap
36.62M USD
Avg Volume
2.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.07M | -25.30% |
Net income | -6.05M | 22.98% |
Net profit margin | — | — |
Earnings per share | -0.12 | 53.85% |
EBITDA | — | — |
Effective tax rate | -0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.36M | 67.75% |
Total assets | 11.63M | 44.48% |
Total liabilities | 12.09M | -14.19% |
Total equity | -459.15K | — |
Shares outstanding | 68.00M | — |
Price to book | -52.00 | — |
Return on assets | -162.28% | — |
Return on capital | 662.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.05M | 22.98% |
Cash from operations | -5.01M | 40.86% |
Cash from investing | — | — |
Cash from financing | 10.09M | 276.28% |
Net change in cash | 5.07M | 187.56% |
Free cash flow | -2.21M | 52.83% |
About
Founded
2018
Headquarters
Website
Employees
14
